Delivery Order SPE2DB22D1052-SPE2DB23FU9TS
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,065.16 fixed-price contract is for the supply of 4,562,853,079 tablets of the medication Sucralfate 1 gram. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,339.02, is for the delivery of 4,563,250,149 units of Sucralfate 1 GM Tablet 90S, a medication used to treat certain stomach and esophagus problems. This is a firm fixed-price delivery order contract with a period of performance through January 8, 2024. The contract is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4559701395 sucralfate 1 gram tablets. The $12,521.90 firm fixed-price delivery order, which has an ultimate completion date of January 25, 2023, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,583.25 contract is for the delivery of 90 1 GM tablets of the medication Sucralfate. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award, valued at $2,196.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension, a pharmaceutical product, and has a completion date of May 14, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award, ID SPE2DX15D1022|SPE2DX24FVDJL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,335.78 firm fixed-price delivery order is for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML containers, with a completion date of February 8, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $28,354.41, is for the delivery of 4,564,072,867 units of the pharmaceutical product Sucralfate 1 GM Tablet, with an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 420 ml bottles of Sucralfate 1 GM/10 ML suspension. The $1,163.86 firm fixed-price delivery order has a completion date of February 8, 2023 and was awarded on February 7, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,586.16, is for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles. The order has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order with a firm fixed price of $1,174.55 for the supply of Sucralfate 1 GM/10 ML Suspension Cups. The award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which falls under the Department of Defense. The contract has a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB23FU9TSDelivery Order
This federal contract award, valued at $31,577.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,217,345 units of Sucralfate 1 GM Tablet 90S, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.6k | 9/18/23 |